Oncotarget: Efavirenz induces DNA damage response pathway in lung cancer
The cover for Issue 41 of Oncotarget features Figure 7, "IPA ATM-signaling pathway in (A) EFV treated MRC-5 and (B) ...
The cover for Issue 41 of Oncotarget features Figure 7, "IPA ATM-signaling pathway in (A) EFV treated MRC-5 and (B) ...
Oncotarget Volume 11, Issue 29 reported that acute myeloid leukemia is a heterogeneous malignancy with the most common genomic alterations ...
Volume 11, Issue 26 of Oncotarget reported that Lung cancer is of particular importance, as it is the deadliest cancer ...
Volume 11, Issue 26 of Oncotarget reported that in this study the authors studied the differences in mi RNA expression ...
Volume 11, Issue 28 of Oncotarget features "Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors ...
Volume 11, Issue 28 of Oncotarget features "Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation" ...
Dashboard reduced preparation time by 30%, improved access to data and decision-makingCredit: Justin Kelley Multidisciplinary tumor boards are vital to ...
The cover for issue 40 of Oncotarget features Figure 5, 'miR-210 silences the proapoptosis member CASP8AP2,' by Kling, et al. ...
Credit: UVA Health Ambitious efforts at UVA Cancer Center to improve care delivered to patients with cancer that has spread ...
Credit: Pixabay user Vanessafrazao Pathogens found in tissues that surround the teeth contribute to a highly aggressive type of oral ...
Researchers at the Medical University of South Carolina and Hollings Cancer Center explore remote methods for conducting smoking cessation clinical ...
The cover for issue 38 of Oncotarget features Figure 3, 'Summary of the time and cost for drug development (modified ...
Credit: University of Ottawa Jennifer Keir, a uOttawa PhD student and Research Associate whose research investigates firefighters' health and their ...
The cover for issue 36 of Oncotarget features Figure 7, 'Knockdown of APOBEC3B is associated with a lower tumor growth ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.